HSBC Holdings
CLPT icon

HSBC Holdings’s ClearPoint Neuro CLPT Stock Holding History

HSBC Holdings’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Buy
+14,141
New +$179K ﹤0.01% 2714
2025
Q4 		– Sell
-31,616
Closed -$677K – 2970
2025
Q3 		$677K Buy
31,616
+14,992
+90% +$177K ﹤0.01% 1957
2025
Q2 		$199K Buy
+16,624
New +$209K ﹤0.01% 2680

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

HSBC Holdings's CLPT Position: Q1 2026 in Review

HSBC Holdings opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 14,141 shares worth $129K. The stake represents ﹤0.01% of the portfolio and ranks #2714 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in CLPT as recently as Q3 2025.

HSBC Holdings first reported a position in CLPT in Q2 2025 and has held it in 3 quarters since. The position peaked at $677K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • HSBC Holdings held 14,141 shares of ClearPoint Neuro worth $129K as of Q1 2026.
  • ClearPoint Neuro was a new HSBC Holdings position in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2714 holding.
  • HSBC Holdings first reported a position in ClearPoint Neuro in Q2 2025 and has held it in 3 quarters since.
  • HSBC Holdings's ClearPoint Neuro position peaked at $677K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.